Drug Shortage Report for TARO-TESTOSTERONE
Report ID | 158670 |
Drug Identification Number | 02421186 |
Brand name | TARO-TESTOSTERONE |
Common or Proper name | TESTOSTERONE |
Company Name | TARO PHARMACEUTICALS INC |
Market Status | MARKETED |
Active Ingredient(s) | TESTOSTERONE UNDECANOATE |
Strength(s) | 40MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging size | 6 |
ATC code | G03BA |
ATC description | ANDROGENS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-03-03 |
Estimated end date | 2022-04-15 |
Actual end date | 2022-07-07 |
Shortage status | Resolved |
Updated date | 2022-08-05 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 130 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2022-08-05 | French | Compare |
v3 | 2022-08-05 | English | Compare |
v2 | 2022-04-12 | French | Compare |
v1 | 2022-04-12 | English | Compare |
Showing 1 to 4 of 4